Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 4, Pages e1349588
Publisher
Informa UK Limited
Online
2017-07-17
DOI
10.1080/2162402x.2017.1349588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aptamer-Targeted Attenuation of IL-2 Signaling in CD8 + T Cells Enhances Antitumor Immunity
- (2017) Anugraha Rajagopalan et al. MOLECULAR THERAPY
- Targeting T Cell Co-receptors for Cancer Therapy
- (2016) Margaret K. Callahan et al. IMMUNITY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- A Critical Role for Transcription Factor Smad4 in T Cell Function that Is Independent of Transforming Growth Factor β Receptor Signaling
- (2015) Ai-Di Gu et al. IMMUNITY
- Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery
- (2015) E. Gilboa et al. Cancer Immunology Research
- Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
- (2014) B. Schrand et al. Cancer Immunology Research
- Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
- (2014) Jiehua Zhou et al. Molecular Therapy-Nucleic Acids
- Human CD1c+ Dendritic Cells Drive the Differentiation of CD103+ CD8+ Mucosal Effector T Cells via the Cytokine TGF-β
- (2013) Chun I. Yu et al. IMMUNITY
- A daunting task: manipulating leukocyte function with RNAi
- (2013) Dan Peer IMMUNOLOGICAL REVIEWS
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- Truncated Form of TGF- RII, But Not Its Absence, Induces Memory CD8+ T Cell Expansion and Lymphoproliferative Disorder in Mice
- (2013) H. Ishigame et al. JOURNAL OF IMMUNOLOGY
- Excessive Th1 responses due to the absence of TGF- signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis
- (2013) H. Ishigame et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF- and v 6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression
- (2012) A. F. Hezel et al. CANCER RESEARCH
- Molecular Pathways: Targeting the TGF- Pathway for Cancer Therapy
- (2012) A. L. Smith et al. CLINICAL CANCER RESEARCH
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Wnt5a Potentiates TGF- Signaling to Promote Colonic Crypt Regeneration After Tissue Injury
- (2012) H. Miyoshi et al. SCIENCE
- Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
- (2012) Alexey Berezhnoy et al. Molecular Therapy-Nucleic Acids
- Improving cancer immunotherapy by targeting tumor-induced immune suppression
- (2011) Trina J. Stewart et al. CANCER AND METASTASIS REVIEWS
- Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T RI/II Kinase Inhibition with LY2109761
- (2011) E. C. Connolly et al. CANCER RESEARCH
- T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
- (2011) Moses K. Donkor et al. IMMUNITY
- Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
- (2011) Xiaohua Ni et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
- (2011) Lee Adam Wheeler et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
- (2011) Fernando Pastor et al. MOLECULAR THERAPY
- An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice
- (2011) C. P. Neff et al. Science Translational Medicine
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Transforming growth factor-beta: A target for cancer therapy
- (2009) Ronan J. Kelly et al. Journal of Immunotoxicology
- Companies Waver in Efforts To Target Transforming Growth Factor in Cancer
- (2009) K. Garber JNCI-Journal of the National Cancer Institute
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
- (2009) Justin P Dassie et al. NATURE BIOTECHNOLOGY
- Transforming Growth Factor : Tumor Suppressor or Promoter? Are Host Immune Cells the Answer?
- (2008) L. Yang et al. CANCER RESEARCH
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Overcoming the Innate Immune Response to Small Interfering RNA
- (2008) Adam Judge et al. HUMAN GENE THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started